Clinical Trials in Miami

Showing 2961-2980 of 9,821 trials

Oxygenation Instability and Maturation of Control of Breathing in Premature Infants

NCT03445689

Premature infants present with significant oxygenation instability in the form of frequent spontaneous episodes of hypoxemia during the first weeks after birth. These infants are also exposed to hyperoxemia. The objective of this study is to determine the extent to which exposure to frequent episodes of hypoxemia and hyperoxemia in extreme premature infants during the early stages of their evolving lung disease is associated with altered maturation and function of their respiratory control system. This study is part of the Prematurity-Related Ventilatory Control (Pre-Vent): Role in Respiratory Outcomes Clinical Research Centers (CRC) (U01) cooperative program of the National Heart Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH).

Infant,Premature

University of Miami70 participantsStarted Sep 2018

Miami, Florida, United States

COMPLETEDPhase 1/2< 1 mile

Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age and Older

NCT05624606

The purpose of this study is to evaluate the safety and immunogenicity of a single intramuscular (IM) injection of up to 3 dose levels of Quadrivalent Influenza mRNA Vaccine MRT5410 compared to an active control (QIV SD, QIV HD \[adults ≥ 65 years of age only\], or RIV4) in adults 18 years of age and older.

Influenza Immunization

Sanofi Pasteur, a Sanofi Company682 participantsStarted Nov 2022

Huntington Park, California, United States • Long Beach, California, United States • North Hollywood, California, United States +22 more locations

Oxygenation Instability and Maturation of Control of Breathing in Premature Infants

Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age and Older

Find Trials by Condition in Miami

Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors

AGEN1884, an Anti-CTLA-4 Human Monoclonal Antibody in Participants With Advanced or Refractory Cancer and Who Have Progressed With PD-1/PD-L1 Inhibitor as Their Most Recent Therapy

Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions

SAD Evaluation of Safety, Tolerability, PK, and PD of MDI-2517 in Healthy Participants

Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study

DUET Study: A Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy and in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic Steatohepatitis

Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines

Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis

An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.

A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases

A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma

A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer

A Study of LY3561774 in Participants With Mixed Dyslipidemia

Safety and Immunogenicity of HIL-214 With Routine Pediatric Vaccines

SNV1521 in Participants with Advanced Solid Tumors

ALXN1210 Versus Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab

Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: the VAPOR-C Trial

Infant Mortality Reduction by the Mass Administration of Azithromycin